Skip to main content
OpenTrials

Clinical trial condition

IDH Wild-type and STAT3-positive Glioblastoma

Explore clinical trials studying IDH Wild-type and STAT3-positive Glioblastoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

IDH Wild-type and STAT3-positive Glioblastoma trial results

Recruiting

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

NCT06964815

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna, BO, Italy
  • IRST Dino Amadori Meldola, FC, Italy
  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco " Catania, Italia/Catania, Italy
  • Azienda Ospedaliera Universitaria - Careggi Florence, Italia/FI, Italy
View all 16 locations
View Trial Details

Related conditions